OCUMENSION-B (01477.HK) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Quote List Quote List

Event Tracking

Aug27

CICC Raises Target Price for Ocuvita Biotech to HKD 10.16

03:15

Aug25

Ocumetrix Biotech Sees Significant Revenue Growth in 2025 H1

02:32

Aug21

OCUMENSION-B released FY2025 Q1 earnings on August 21, 2025 (BJT) with actual revenue of HKD 157.45 M and EPS of HKD -0.0897

15:00

Oculeve's OT-301 drug reaches primary endpoint in Phase III clinical trial

11:52

OCUMENSION-B released FY2025 Q2 earnings on August 21 During-Market (BJT), actual revenue HKD 160.91 M, actual EPS HKD -0.0917

08:00

OCUMENSION-B released FY2025 Semi-Annual Earnings on August 21 During-Market (BJT), actual revenue HKD 318.36 M (forecast HKD 347.7 M), actual EPS HKD -0.1815 (forecast HKD -0.1313)

08:00

Schedules & Filings

Schedules

Filings

Aug21

Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 160.91 M, Net Income -72.41 M, EPS -0.0917

Mar31

Earning Release(CST)

FY2024 Q4 Earning Release (HKD) Revenue 132.81 M, Net Income -62.2 M, EPS -0.0878

Aug12

Earning Release(CST)

FY2024 Q2 Earning Release (HKD) Revenue 90.06 M, Net Income -81.31 M, EPS -0.1235

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change